Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Oct 1.

Published in final edited form as: Eur J Cancer. 2012 Mar 19;48(15):2319–2327. doi: 10.1016/j.ejca.2012.02.065

Fig. 2 — Cumulative incidence of HCC by (A) median and (B) tertile distribution of baseline AFP level, conducted within patients with baseline AFP measured within 6 months of first clinical visit and a minimum of 36 months’ of follow-up.

Fig. 2 — Cumulative incidence of HCC by (A) median and (B) tertile distribution of baseline AFP level, conducted within patients with baseline AFP measured within 6 months of first clinical visit and a minimum of 36 months’ of follow-up.